Scale -


  • Revenue is 1875 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • Ebitda is 562 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 22 %
  • PBT is 116 Rs Cr; in Top Quartile; 5 Year CAGR is 22 %
  • PAT is 315 Rs Cr; in Top Quartile; 5 Year CAGR is 22 %
  • Quarterly Revenue is 525 Rs Cr; in Top Quartile

Profitability -


  • PAT Margin is 16.8 %; in Top Quartile; Annual Decline is -16 %
  • Quarterly Profit margin is 16 %; in Top Quartile

Return -


  • ROA is 8.22 %; Annual Decline is -22 %; Continuous Decline over 3 years
  • ROCE is 13.36 %; Continuous Decline over 3 years
  • ROE is 10.37 %; Continuous Decline over 3 years
  • Asset Turnover is 53 %; Continuous Decline over 3 years; in Bottom Quartile

Efficiency -


  • Operating cash flow is 241 Rs Cr; in Top Quartile
  • Inventory Turnover Ratio is 5.21; 5 Year CAGR is 22 %
  • Current Ratio is 3.37; Annual Decline is -35 %
  • Quick Ratio is 2.62; Annual Decline is -41 %

Solvancy -


  • Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %
  • Debt/Equity is 0.11; Annual Growth is 83 %
  • Total Debt is 342 Rs Cr; Annual Growth is 92 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 29 %
  • Long term Debt is 52.09 Rs Cr; in Top Quartile

Quality -


  • Exceptional Items/PBT is -2 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 0 %; Annual Growth is 74 %
  • Operating cashflow/ebitda is 43 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 28 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
What Are Pharma Brand, Medical Device and Diagnostic Chain Stocks?
Poly Medicure (NSEI:POLYMED) Stock Forecast & Analyst Predictions